In this review, we detail the changes and the relevant features that are applied to
neuroendocrine neoplasms (NENs) in the 2022 WHO Classification of Endocrine and …

The classification of neuroendocrine neoplasms (NENs) differs between organ systems and
currently causes considerable confusion. A uniform classification framework for NENs at any …

This review covers the diverse topic of neuroendocrine neoplasms (NENs), a relatively rare
and heterogeneous tumor type, comprising~ 2% of all malignancies, with a prevalence of< …

Much recent debate has focused on the optimal classification of epithelial neuroendocrine
tumors (NETs). Multiple different systems of terminology, grading, and staging have been …

Metastatic and locally-advanced neuroendocrine neoplasms (aNEN) form clinically and
genetically heterogeneous malignancies, characterized by distinct prognoses based upon …

Neuroendocrine tumors (NETs) arise in most organs of the body and share many common
pathologic features. However, a variety of different organ-specific systems have been …

Neuroendocrine neoplasia is described in almost every tissue, either in the pure endocrine
organs, the nerve structures or in the so-called diffuse neuroendocrine system. The current …

Background Gastroenteropancreatic neuroendocrine neoplasms (GEP‐NENs) are a
complex family of tumors of widely variable clinical behavior. The World Health Organization …

Neuroendocrine neoplasms (NENs) are heterogeneous tumors with a common phenotype.
There are two fundamentally different groups of NENs: well-differentiated, low-proliferating …

Neuroendocrine neoplasms (NENs) are a heterogeneous group of neoplastic proliferations
showing different morphological features, immunophenotype, molecular background …